What are the implications of TAK-285's activity in a brain metastasis model?
Label:chem
Topic
Brain metastases are a significant challenge in cancer treatment due to the blood-brain barrier's (BBB) restriction of drug access. TAK-285's ability to penetrate the BBB and inhibit tumor growth in the CNS is a critical aspect of its potential therapeutic value.
Answer
In a murine intracranial injection model of brain metastasis using BT-474-derived cerebral xenografts, TAK-285 significantly inhibited intracranial tumor growth with a T/C value of 44% on day 41, compared to lapatinib, which showed a T/C value of 73% and was not significantly different from control-treated animals. This suggests that TAK-285 is more effective than lapatinib in treating brain metastases due to its ability to penetrate the BBB and lack of Pgp substrate activity.
Return to Home
Chemical List
Knowledge you may be interested in